Barclays Issues Pessimistic Forecast for Definitive Healthcare (NASDAQ:DH) Stock Price

Definitive Healthcare (NASDAQ:DH) had its price objective dropped by research analysts at Barclays from $2.75 to $1.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Barclays‘s price objective indicates a potential downside of 18.70% from the stock’s previous close.

Other analysts have also issued reports about the company. Canaccord Genuity Group dropped their price objective on Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a report on Friday, February 27th. Zacks Research downgraded Definitive Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, March 5th. Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Finally, Stephens cut their price target on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a report on Friday, February 27th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $3.27.

Definitive Healthcare Trading Up 6.0%

Shares of Definitive Healthcare stock opened at $1.23 on Monday. The firm has a 50-day simple moving average of $1.56 and a two-hundred day simple moving average of $2.43. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. Definitive Healthcare has a fifty-two week low of $0.97 and a fifty-two week high of $4.70. The company has a market cap of $128.50 million, a P/E ratio of -0.98 and a beta of 1.66.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in shares of Definitive Healthcare during the 2nd quarter worth approximately $32,000. State of Alaska Department of Revenue increased its holdings in shares of Definitive Healthcare by 109.3% in the fourth quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after purchasing an additional 5,970 shares during the last quarter. Schonfeld Strategic Advisors LLC purchased a new position in Definitive Healthcare during the fourth quarter worth approximately $35,000. Ariadne Wealth Management LP acquired a new position in Definitive Healthcare during the third quarter worth $54,000. Finally, Bayesian Capital Management LP acquired a new position in Definitive Healthcare during the second quarter worth $55,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.